People on GLP-1s who have developed a sudden aversion to steak, burgers and chicken are calling their newfound disgust the "meat ick." (Getty Images) Merris Taylor has never loved a fatty ribeye or ...
People who stopped taking GLP-1s regained weight within two months. People who stop taking GLP-1 medications like Wegovy and Zepbound started to regain weight in a short amount of time, a new study ...
The use of GLP-1 receptor agonists, and particularly liraglutide, was associated with an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) during the first year of ...
July 14 (UPI) --Folks using GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, a new study says. People with type 2 diabetes were more likely to suffer from ...
GLP-1 weight loss treatment can be pricey. But employers who cover the treatments could end up saving on employee medical expenses overall. The finding is according to a new analysis of health ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.
Aug 22 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results